4,839
Views
16
CrossRef citations to date
0
Altmetric
Review

Research progress on therapeutic targeting of quiescent cancer cells

, , , , , , , & show all
Pages 2810-2819 | Received 20 May 2019, Accepted 24 Jun 2019, Published online: 09 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tajindra Singh Saluja, Vijay Kumar, Monika Agrawal, Abhilasha Tripathi, Rajesh Kumar Meher, Kamini Srivastava, Anurag Gupta, Anjana Singh, Arun Chaturvedi & Satyendra Kumar Singh. (2020) Mitochondrial Stress–Mediated Targeting of Quiescent Cancer Stem Cells in Oral Squamous Cell Carcinoma. Cancer Management and Research 12, pages 4519-4530.
Read now

Articles from other publishers (15)

Ebrahim H. Maleki, Ahmad Reza Bahrami & Maryam M. Matin. (2024) Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance. Genes & Diseases 11:1, pages 189-204.
Crossref
Jiangjun Cao, Zhe Zhang, Li Zhou, Maochao Luo, Lei Li, Bowen Li, Edouard C. Nice, Weifeng He, Shaojiang Zheng & Canhua Huang. (2023) Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy. MedComm 4:6.
Crossref
Jinhua Zhang, Yi Xie, Xiaoyi Liu, Lu Gan, Pingping Li, Zhihui Dou, Cuixia Di, Hong Zhang & Jing Si. (2023) Carbon ions trigger DNA damage response to overcome radioresistance by regulating β‐catenin signaling in quiescent HeLa cells. Journal of Cellular Physiology 238:8, pages 1836-1849.
Crossref
Enyi Gao, Xiaoya Sun, Rick Francis Thorne, Xu Dong Zhang, Jinming Li, Fengmin Shao, Jianli Ma & Mian Wu. (2023) NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells. Journal of Translational Medicine 21:1.
Crossref
Emma Lindell, Lei Zhong & Xiaonan Zhang. (2023) Quiescent Cancer Cells—A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse. International Journal of Molecular Sciences 24:4, pages 3762.
Crossref
Lina Alhaddad, Andreyan N. Osipov & Sergey Leonov. (2022) The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance. International Journal of Molecular Sciences 23:21, pages 13577.
Crossref
Philipp Globig, Regine Willumeit-Römer, Fernanda Martini, Elisa Mazzoni & Bérengère J.C. Luthringer-Feyerabend. (2022) Slow degrading Mg-based materials induce tumor cell dormancy on an osteosarcoma-fibroblast coculture model. Bioactive Materials 16, pages 320-333.
Crossref
Frederika Rentzeperis & Dorothy Wallace. (2022) Local and global sensitivity analysis of spheroid and xenograft models of the acid-mediated development of tumor malignancy. Applied Mathematical Modelling 109, pages 629-650.
Crossref
Riccardo Di Fiore, Sherif Suleiman, Rosa Drago-Ferrante, Yashwanth Subbannayya, Francesca Pentimalli, Antonio Giordano & Jean Calleja-Agius. (2022) Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review. International Journal of Molecular Sciences 23:9, pages 5167.
Crossref
Minas Sakellakis, Laura Flores & Sumankalai Ramachandran. (2022) Patterns of indolence in prostate cancer (Review). Experimental and Therapeutic Medicine 23:5.
Crossref
Win Sen Heng, Frank A. E. Kruyt & Shiau-Chuen Cheah. (2021) Understanding Lung Carcinogenesis from a Morphostatic Perspective: Prevention and Therapeutic Potential of Phytochemicals for Targeting Cancer Stem Cells. International Journal of Molecular Sciences 22:11, pages 5697.
Crossref
Jinhua Zhang, Jing Si, Lu Gan, Rong Zhou, Menghuan Guo & Hong Zhang. (2020) Harnessing the targeting potential of differential radiobiological effects of photon versus particle radiation for cancer treatment. Journal of Cellular Physiology 236:3, pages 1695-1711.
Crossref
Xiao Lei, Na Ma, Lehui Du, Yanjie Liang, Pei Zhang, Yanan Han & Baolin Qu. (2020) PP2A and tumor radiotherapy. Hereditas 157:1.
Crossref
Susana Fiorentino, Claudia Urueña, Paola Lasso, Karol Prieto & Alfonso Barreto. (2020) Phyto-Immunotherapy, a Complementary Therapeutic Option to Decrease Metastasis and Attack Breast Cancer Stem Cells. Frontiers in Oncology 10.
Crossref
Evelina Folkesson, Barbara Niederdorfer, Vu To Nakstad, Liv Thommesen, Geir Klinkenberg, Astrid Lægreid & Åsmund Flobak. (2020) High-throughput screening reveals higher synergistic effect of MEK inhibitor combinations in colon cancer spheroids. Scientific Reports 10:1.
Crossref